- Home
- CCU vs NVAX Comparison
CCU vs NVAX Comparison
Compare CCU & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- NVAX
- Stock Information
- Founded
- CCU 1850
- NVAX 1987
- Country
- CCU Chile
- NVAX United States
- Employees
- CCU N/A
- NVAX N/A
- Industry
- CCU Beverages (Production/Distribution)
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCU Consumer Staples
- NVAX Health Care
- Exchange
- CCU Nasdaq
- NVAX Nasdaq
- Market Cap
- CCU 2.4B
- NVAX 1.3B
- IPO Year
- CCU 1992
- NVAX 1995
- Fundamental
- Price
- CCU $13.33
- NVAX $7.12
- Analyst Decision
- CCU Strong Sell
- NVAX Buy
- Analyst Count
- CCU 2
- NVAX 5
- Target Price
- CCU $9.70
- NVAX $16.60
- AVG Volume (30 Days)
- CCU 213.4K
- NVAX 5.1M
- Earning Date
- CCU 08-06-2025
- NVAX 08-07-2025
- Dividend Yield
- CCU 2.06%
- NVAX N/A
- EPS Growth
- CCU 67.38
- NVAX N/A
- EPS
- CCU 0.47
- NVAX 2.97
- Revenue
- CCU $3,126,996,945.00
- NVAX $1,254,962,000.00
- Revenue This Year
- CCU $9.09
- NVAX $56.85
- Revenue Next Year
- CCU $4.83
- NVAX N/A
- P/E Ratio
- CCU $14.17
- NVAX $2.37
- Revenue Growth
- CCU 15.38
- NVAX 25.92
- 52 Week Low
- CCU $10.00
- NVAX $5.01
- 52 Week High
- CCU $15.75
- NVAX $17.81
- Technical
- Relative Strength Index (RSI)
- CCU 50.63
- NVAX 57.25
- Support Level
- CCU $13.18
- NVAX $6.54
- Resistance Level
- CCU $13.60
- NVAX $6.90
- Average True Range (ATR)
- CCU 0.30
- NVAX 0.29
- MACD
- CCU 0.11
- NVAX 0.06
- Stochastic Oscillator
- CCU 76.52
- NVAX 92.52
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.